ZA200805763B - Cationic steroid antimicrobial compositions and methods of use - Google Patents

Cationic steroid antimicrobial compositions and methods of use

Info

Publication number
ZA200805763B
ZA200805763B ZA200805763A ZA200805763A ZA200805763B ZA 200805763 B ZA200805763 B ZA 200805763B ZA 200805763 A ZA200805763 A ZA 200805763A ZA 200805763 A ZA200805763 A ZA 200805763A ZA 200805763 B ZA200805763 B ZA 200805763B
Authority
ZA
South Africa
Prior art keywords
methods
antimicrobial compositions
cationic steroid
steroid antimicrobial
cationic
Prior art date
Application number
ZA200805763A
Other languages
English (en)
Inventor
Paul B Savage
Unutmaz Derya
Original Assignee
Univ Brigham Young
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brigham Young, Univ Vanderbilt filed Critical Univ Brigham Young
Publication of ZA200805763B publication Critical patent/ZA200805763B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
ZA200805763A 2006-02-01 2008-07-01 Cationic steroid antimicrobial compositions and methods of use ZA200805763B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76399906P 2006-02-01 2006-02-01

Publications (1)

Publication Number Publication Date
ZA200805763B true ZA200805763B (en) 2009-08-26

Family

ID=38320187

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200805763A ZA200805763B (en) 2006-02-01 2008-07-01 Cationic steroid antimicrobial compositions and methods of use

Country Status (7)

Country Link
US (1) US20070190067A1 (xx)
EP (1) EP1978968A2 (xx)
CN (2) CN101378761B (xx)
AU (1) AU2007211279B2 (xx)
CA (1) CA2640584C (xx)
WO (1) WO2007089907A2 (xx)
ZA (1) ZA200805763B (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2303026B1 (en) * 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US8975310B2 (en) * 2011-07-20 2015-03-10 Brigham Young University Hydrophobic ceragenin compounds and devices incorporating same
US8932614B2 (en) 2011-08-25 2015-01-13 Paul B. Savage Incorporation of particulate ceragenins in polymers
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
CA2852989C (en) 2011-09-13 2021-06-29 Brigham Young University Compositions for treating bone diseases and broken bones
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
MX369385B (es) 2011-09-13 2019-11-07 Univ Brigham Young Productos para cicatrizar heridas tisulares.
JP6051230B2 (ja) * 2011-12-21 2016-12-27 ブリガム ヤング ユニバーシティ 口腔ケア組成物
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
EP3225113B1 (en) * 2012-05-02 2020-09-02 Brigham Young University Methods for making ceragenin particulate materials
WO2014062960A1 (en) 2012-10-17 2014-04-24 Brigham Young University Treatment and prevention of mastitis
CA2897150C (en) 2013-01-07 2021-07-13 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
RU2669800C2 (ru) 2013-03-15 2018-10-16 Брихэм Янг Юниверсити Способы лечения воспаления, аутоиммунных расстройств и боли
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) * 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US9867836B2 (en) * 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10441595B2 (en) * 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) * 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
WO2016086115A1 (en) 2014-11-26 2016-06-02 Enanta Pharmaceuticals, Inc. Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof
US10208081B2 (en) 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
KR20170099909A (ko) 2014-11-26 2017-09-01 이난타 파마슈티칼스, 인코포레이티드 Fxr/tgr5 작용제로서의 담즙산 유사체 및 이의 이용 방법
DK3277286T3 (da) 2015-03-31 2021-07-05 Enanta Pharm Inc Galdesydererivater som fxr/tgr5-agonister og anvendelsesmetoder deraf
WO2016172543A1 (en) * 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
CN108348532A (zh) * 2015-04-22 2018-07-31 布莱阿姆青年大学 塞拉集宁的合成方法
EP3285875B1 (en) * 2015-04-22 2020-11-11 Brigham Young University Methods for the synthesis of ceragenins
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10323060B2 (en) 2016-02-23 2019-06-18 Enanta Pharmaceuticals, Inc. Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
JP7057783B2 (ja) 2016-11-29 2022-04-20 エナンタ ファーマシューティカルズ インコーポレイテッド スルホニル尿素胆汁酸誘導体の調製方法
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
MX2019011844A (es) 2017-04-07 2021-11-30 Enanta Pharm Inc Proceso para la preparación de derivados de ácidos biliares de sulfonil carbamato.
CN110327351B (zh) * 2019-08-13 2022-04-15 山东大学 贝韦立马在制备抑制弓形虫生长的药物中的应用
CN111265499B (zh) * 2020-02-17 2022-11-15 江苏艾立康医药科技有限公司 一种洛匹那韦吸入气雾剂及其制备方法
CN117402202B (zh) * 2023-12-15 2024-02-13 成都贝诺科成生物科技有限公司 一种化合物及其制备方法和用途以及含该化合物的药物组合物和医疗器械涂层

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5529776A (en) * 1988-07-06 1996-06-25 Verigen Inc. Anti-HIV-1 neutralizing antibodies
WO1996008270A2 (en) * 1994-09-13 1996-03-21 Magainin Pharmaceuticals Inc. Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
US5736430A (en) * 1995-06-07 1998-04-07 Ssi Technologies, Inc. Transducer having a silicon diaphragm and method for forming same
US6143738A (en) * 1995-06-07 2000-11-07 Magainin Pharmaceuticals, Inc. Therapeutic uses for an aminosterol compound
US5763430A (en) * 1995-06-07 1998-06-09 Magainin Pharmaceuticals Inc. Method of treating a viral infection by administering a steroid compound
US6767902B2 (en) * 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US6767904B2 (en) * 1998-03-06 2004-07-27 Bringham Young University Steroid derived antibiotics
US6350738B1 (en) * 1998-03-06 2002-02-26 Brigham Young University Steroid derived antibiotics

Also Published As

Publication number Publication date
WO2007089907A2 (en) 2007-08-09
CN101378761A (zh) 2009-03-04
EP1978968A2 (en) 2008-10-15
CN102145005A (zh) 2011-08-10
CA2640584A1 (en) 2007-08-09
AU2007211279A1 (en) 2007-08-09
US20070190067A1 (en) 2007-08-16
AU2007211279B2 (en) 2013-02-14
CN101378761B (zh) 2013-10-16
WO2007089907A3 (en) 2007-11-01
CA2640584C (en) 2015-12-01

Similar Documents

Publication Publication Date Title
ZA200805763B (en) Cationic steroid antimicrobial compositions and methods of use
HRP20180497T1 (hr) Antimikrobni pripravci i odgovarajući postupci njihove upotrebe
GB2469245B (en) Antimicrobial compositions and methods of use thereof
IL209507A0 (en) Antimicrobial compositions and methods of use thereof
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
HK1172326A1 (en) Compounds and compositions and methods of use
EP2326171A4 (en) ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
HK1133381A1 (en) Antimicrobial agent and antimicrobial composition
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
PL2346327T3 (pl) Kompozycje biobójcze i sposoby stosowania
ZA200808431B (en) Fungicidal compositions and methods of using the same
EP2346324A4 (en) ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING
EP2276339A4 (en) ANTIMICROBIAL COMPOSITION AND USE
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
EP2170404A4 (en) COMPOSITIONS WITH HUMAN EGFR SIRNA AND METHOD OF USE
EP2069452A4 (en) ONIUM-HOLDING CMP COMPOSITIONS OF BIOACTIVE COMPLEXES AND METHOD FOR THEIR USE
IL192564A0 (en) Composition and method of use thereof
ZA201004894B (en) Nuctraceutical composition and methods of use
ZA201004893B (en) Nuctraceutical composition and methods of use
EP2149601A4 (en) SOLUBILIZED AMNIOS COMPOSITION AND USE THEREOF
ZA200806668B (en) Antiseptic compositions and methods of using same
IL192614A0 (en) Antiseptic compositions and methods of using same
GB0602871D0 (en) Use Of Anti-Microbial Compositions And Novel Methods For The Delivery Of Such Compositions
AU2006902484A0 (en) Compositions and methods of use thereof
GB0720518D0 (en) Compositions and their use